Novel mitoNEET ligand NL-1 improves therapeutic outcomes in an aged rat model of cerebral ischemia/reperfusion injury

Pharmacology, Toxicology and Pharmaceutical Science

• Rat Model 100%
• Ligand 100%
• Brain Ischemia 100%
• Reperfusion Injury 100%
• Drug 75%
• Rat 75%
• Middle Cerebral Artery Occlusion 50%
• Lipid 25%
• Survival 25%
• Injury 25%
• Mortality 25%
• Nanoparticle 25%
• Infarction 25%
• Brain Injury 25%
• Mitochondrial Protein 25%
• Disability 25%
• Cerebrovascular Accident 25%
• 4 Hydroxynonenal 25%
• Swelling 25%
• Blood-Brain Barrier 25%

Neuroscience

• Cerebral Ischemia-Reperfusion Injury 100%
• Brain Ischemia 100%
• Brain 66%
• Female Rats 66%
• Middle Cerebral Artery 66%
• Reperfusion Injury 66%
• Brain Injury 33%
• PLGA 33%
• Blood Brain Barrier 33%
• Mitochondrial Protein 33%
• Cell Loss 33%
• Lipid Peroxidation 33%
• Cerebrovascular Accident 33%